These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18830924)

  • 1. Gene therapy of cardiovascular disease.
    Nikol S
    Curr Opin Mol Ther; 2008 Oct; 10(5):479-92. PubMed ID: 18830924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for cardiovascular disease: the potential of VEGF.
    Tiong A; Freedman SB
    Curr Opin Mol Ther; 2004 Apr; 6(2):151-9. PubMed ID: 15195927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?
    Francis SC; Raizada MK; Mangi AA; Melo LG; Dzau VJ; Vale PR; Isner JM; Losordo DW; Chao J; Katovich MJ; Berecek KH
    Physiol Genomics; 2001 Dec; 7(2):79-94. PubMed ID: 11773594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gene therapy in heart diseases].
    Tanner FC; Largiadèr T; Yang Z; Lüscher TF
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1784-91. PubMed ID: 10603653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does gene therapy become pharmacotherapy?
    Morishita R; Aoki M; Ogihara T
    Exp Physiol; 2005 May; 90(3):307-13. PubMed ID: 15778409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy in vascular disease.
    Sedighiani F; Nikol S
    Surgeon; 2011 Dec; 9(6):326-35. PubMed ID: 22041646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation?
    Lekas M; Lekas P; Latter DA; Kutryk MB; Stewart DJ
    Curr Opin Cardiol; 2006 Jul; 21(4):376-84. PubMed ID: 16755208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alferminogene tadenovec, an angiogenic FGF4 gene therapy for coronary artery disease.
    Flynn A; O'Brien T
    IDrugs; 2008 Apr; 11(4):283-93. PubMed ID: 18379964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-viral vectors for gene therapy: clinical trials in cardiovascular disease.
    Shah PB; Losordo DW
    Adv Genet; 2005; 54():339-61. PubMed ID: 16096018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New aspects in vascular gene therapy.
    Karvinen H; Ylä-Herttuala S
    Curr Opin Pharmacol; 2010 Apr; 10(2):208-11. PubMed ID: 20163988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular gene therapy].
    Hansen PR
    Ugeskr Laeger; 1997 Nov; 159(48):7124-8. PubMed ID: 9417717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic gene therapy strategies for the treatment of cardiovascular disease.
    Rasmussen HS; Rasmussen CS; Macko J; Yonehiro G
    Curr Opin Mol Ther; 2002 Oct; 4(5):476-81. PubMed ID: 12435049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prospects for gene therapy of cardiovascular diseases].
    Parfenova EV; Tkachuk VA
    Vopr Med Khim; 2000; 46(3):293-310. PubMed ID: 11033888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NV1FGF, a pCOR plasmid-based angiogenic gene therapy for the treatment of intermittent claudication and critical limb ischemia.
    Maulik N
    Curr Opin Investig Drugs; 2009 Mar; 10(3):259-68. PubMed ID: 19333884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenic and antiangiogenic gene therapy.
    Malecki M; Kolsut P; Proczka R
    Gene Ther; 2005 Oct; 12 Suppl 1():S159-69. PubMed ID: 16231050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic gene regulation: targeting transcription.
    Giordano FJ
    Circulation; 2007 Mar; 115(10):1180-3. PubMed ID: 17353455
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials.
    Ylä-Herttuala S; Markkanen JE; Rissanen TT
    Trends Cardiovasc Med; 2004 Nov; 14(8):295-300. PubMed ID: 15596105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis: protein, gene, or cell therapy?
    Fedak PW; Verma S; Weisel RD; Mickle DA; Li RK
    Heart Surg Forum; 2001; 4(4):301-4. PubMed ID: 11827855
    [No Abstract]   [Full Text] [Related]  

  • 19. Viral or non-viral angiogenesis gene transfer-New answers to old questions.
    Nikol S
    Cardiovasc Res; 2007 Feb; 73(3):443-5. PubMed ID: 17196566
    [No Abstract]   [Full Text] [Related]  

  • 20. [Possibilities for cardiovascular gene therapy].
    Szelid ZL; Pokreisz P; Janssens S; Polák G
    Orv Hetil; 2005 May; 146(22):1189-96. PubMed ID: 15997664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.